# Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers

> **NCT01639716** · — · COMPLETED · sponsor: **Nil Guler** · enrollment: 58 (actual)

## Conditions studied

- Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01639716
- **Lead sponsor:** Nil Guler
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639716, "Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01639716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*